Jie‐Bin Lew

3.5k total citations · 2 hit papers
61 papers, 2.4k citations indexed

About

Jie‐Bin Lew is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Jie‐Bin Lew has authored 61 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 29 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Jie‐Bin Lew's work include Colorectal Cancer Screening and Detection (31 papers), Cervical Cancer and HPV Research (28 papers) and Global Cancer Incidence and Screening (27 papers). Jie‐Bin Lew is often cited by papers focused on Colorectal Cancer Screening and Detection (31 papers), Cervical Cancer and HPV Research (28 papers) and Global Cancer Incidence and Screening (27 papers). Jie‐Bin Lew collaborates with scholars based in Australia, Netherlands and China. Jie‐Bin Lew's co-authors include Karen Canfell, Megan A. Smith, Kate T. Simms, Marion Saville, Michael Caruana, Michaela Hall, Julia Brotherton, Jufang Shi, Philip E. Castle and Julia Steinberg and has published in prestigious journals such as Bioinformatics, PLoS ONE and Scientific Reports.

In The Last Decade

Jie‐Bin Lew

59 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study

2019 326 citations Kate T. Simms, Julia Steinberg et al. The Lancet Oncology profile →
The projected timeframe until cervical cancer elimination in Australia: a modelling study

2018 301 citations Michaela Hall, Kate T. Simms et al. The Lancet Public Health profile →

Peers

Jie‐Bin Lew

EPIDE

ONCOL

SURGE

PRM

Nieves Ascunce Spain

Raúl Murillo Colombia

Anne F. Rositch United States

Glenn Copeland United States

K. Miriam Elfström Sweden

Atul Budukh India

Elena Matos Argentina

Pierre Vassilakos Switzerland

Surendra S. Shastri India

Diane D. Davey United States

Nieves Ascunce Spain

Jie‐Bin Lew

1.3k ×1.0

EPIDE

1.1k ×0.8

ONCOL

602 ×1.1

SURGE

282 ×1.1

PRM

175 ×0.9

Citations per year, relative to Jie‐Bin Lew Jie‐Bin Lew (= 1×) peers Nieves Ascunce

Countries citing papers authored by Jie‐Bin Lew

Since Specialization

Citations

This map shows the geographic impact of Jie‐Bin Lew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie‐Bin Lew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie‐Bin Lew more than expected).

Fields of papers citing papers by Jie‐Bin Lew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie‐Bin Lew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie‐Bin Lew. The network helps show where Jie‐Bin Lew may publish in the future.

Co-authorship network of co-authors of Jie‐Bin Lew

This figure shows the co-authorship network connecting the top 25 collaborators of Jie‐Bin Lew. A scholar is included among the top collaborators of Jie‐Bin Lew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie‐Bin Lew. Jie‐Bin Lew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lew, Jie‐Bin, Qingwei Luo, Joachim Worthington, et al.. (2025). Recalibrating an Established Microsimulation Model to Capture Trends and Projections of Colorectal Cancer Incidence and Mortality. Medical Decision Making. 45(3). 257–275. 2 indexed citations

Worthington, Joachim, et al.. (2024). Longitudinal screening adherence in the Australian National Bowel Cancer Screening Program from 2006 to 2022. Preventive Medicine. 186. 108095–108095. 1 indexed citations

Wang, Hong, Yanjie Li, Lin Lei, et al.. (2023). Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis. Cancer Medicine. 13(1). e6787–e6787. 9 indexed citations

Worthington, Joachim, Jie‐Bin Lew, Emily He, et al.. (2023). The ‘hot zone policy’ for colorectal cancer screening presents unique risks and opportunities for rural Australia. Australian Journal of Rural Health. 31(3). 580–586. 3 indexed citations

Worthington, Joachim, Lucie de Jonge, Jie‐Bin Lew, et al.. (2023). Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening. EClinicalMedicine. 62. 102081–102081. 14 indexed citations

Worthington, Joachim, Emily He, Jie‐Bin Lew, et al.. (2022). Colonoscopies in Australia – how much does the National Bowel Cancer Screening Program contribute to colonoscopy use?. Public Health Research & Practice. 33(1). 6 indexed citations

Luo, Qingwei, Jie‐Bin Lew, Julia Steinberg, et al.. (2022). Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040. Scientific Reports. 12(1). 3994–3994. 10 indexed citations

Goldsbury, David, Eleonora Feletto, Marianne Weber, et al.. (2021). Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia. PLoS ONE. 16(11). e0260088–e0260088. 10 indexed citations

Jonge, Lucie de, Joachim Worthington, Nicolas Iragorri, et al.. (2021). Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. The Lancet. Gastroenterology & hepatology. 6(4). 304–314. 93 indexed citations

10.

Keane, Adam, Jufang Shi, Kate T. Simms, et al.. (2020). Health economic evaluation of primary human papillomavirus screening in urban populations in China. Cancer Epidemiology. 70. 101861–101861. 8 indexed citations

11.

Worthington, Joachim, Jie‐Bin Lew, Eleonora Feletto, et al.. (2020). Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment. PLoS ONE. 15(2). e0227899–e0227899. 18 indexed citations

12.

Simms, Kate T., Julia Steinberg, Michael Caruana, et al.. (2019). Impact of Scaled up Human Papillomavirus Vaccination and Cervical Screening and the Potential for Global Elimination of Cervical Cancer in 181 Countries, 2020–99: A Modelling Study. Obstetrical & Gynecological Survey. 74(6). 345–347. 16 indexed citations

13.

Liu, Yijun, Adam Keane, Kate T. Simms, et al.. (2019). Development and application of a framework to estimate health care costs in China: The cervical cancer example. PLoS ONE. 14(10). e0222760–e0222760. 9 indexed citations

14.

Simms, Kate T., Julia Steinberg, Michael Caruana, et al.. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology. 20(3). 394–407. 326 indexed citations breakdown →

15.

Lew, Jie‐Bin, Eleonora Feletto, Stephen Wade, et al.. (2019). Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Public Health Research & Practice. 29(2). 34 indexed citations

16.

Hall, Michaela, Kate T. Simms, Jie‐Bin Lew, et al.. (2018). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health. 4(1). e19–e27. 301 indexed citations breakdown →

17.

Simms, Kate T., Michaela Hall, Megan A. Smith, et al.. (2017). Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia. PLoS ONE. 12(1). e0163509–e0163509. 27 indexed citations

18.

Greuter, Marjolein J.E., Johannes Berkhof, Karen Canfell, et al.. (2016). Resilience of a FIT screening programme against screening fatigue: a modelling study. BMC Public Health. 16(1). 1009–1009. 11 indexed citations

19.

Kang, Yoon‐Jung, Dianne L. O’Connell, Jeffrey Tan, et al.. (2015). Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. Cancer Epidemiology. 39(4). 600–611. 13 indexed citations

20.

Smith, Megan A., Jie‐Bin Lew, Robert J. Walker, et al.. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine. 29(48). 9112–9122. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact